EMYRIA LIMITED - Charts / Financials

4.26%

4.9¢

Market Cap $29.96M

Healthcare Biotechnology

Emyria Limited is an Australia-based early-stage drug development company. The Company is... Emyria Limited is an Australia-based early-stage drug development company. The Company is focused on delivering and developing treatments for mental health and select neurological conditions, guided by real-world data collected with patients across its wholly owned clinical service subsidiaries. Its pipeline comprises MDMA analogue drug development and commercialization of novel serotonin-releasing agents. Its Emyria Healthcare provides evidence-based treatment for patients not finding relief from conventional care, while also helping evaluate emerging new therapies like assisted therapy for post-traumatic stress disorder (PTSD) and assisted therapy for treatment-resistant depression. Its Emyria Data is a robust and ethically sourced real-world data gathered with patients and used to improve its therapy and drug development programs. Its Emyria’s Pipeline includes new psychedelic-assisted therapies and drug treatments for mental health and select neurological diseases.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

REFRESH

Last update - 11.56am 08/08/2025 (20 minute delay)

Day
Open	4.7¢		Day High	4.9¢		Day Low	4.7¢
Daily Volume	3174340

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
2	4.8¢	335508		3	4.9¢	262426

Directors & Senior Management

Dr. Michael Gordon Winlo	Managing Director
Ms. Susan Park	Company Secretary
Mr. Greg Hutchinson	Independent Non-Executive Chairman of the Board
Dr. Mohit Kaushal	Non-Executive Director
Dr. Karen L. Smith	Non-Executive Director
Prof. Sir John Tooke	Non-Executive Director

Data source: Refinitiv

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 4.9¢		Change 0.002(4.26%)		Mkt cap ! $29.96M

Open	High	Low	Value	Volume
4.7¢	4.9¢	4.7¢	$152.1K	3.174M

Buyers (Bids)

No.	Vol.	Price($)
2	335508	4.8¢

Sellers (Offers)

Price($)	Vol.	No.
4.9¢	262426	3

View Market Depth

No.	Vol.	Price($)
2	335508	0.048
6	737264	0.047
5	455000	0.046
2	500000	0.045
2	190828	0.044

Price($)	Vol.	No.
0.049	262426	3
0.050	1313775	6
0.051	219999	4
0.052	334007	5
0.053	9999	1

Last trade - 11.21am 08/08/2025 (20 minute delay)


Last 4.8¢		Change 0.002 ( 2.78 %)
Open	High	Low	Volume
4.7¢	4.9¢	4.7¢	814693
Last updated 11.56am 08/08/2025 ?

EMD (ASX) Chart

EMYRIA LIMITED - Charts / Financials

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories